Halozyme Therapeutics CEO Helen Torley sells, buys shares in July 2025.

Halozyme Therapeutics, Inc. [HALO] has announced that Director, President and CEO Torley Helen has engaged in several transactions involving the sale and purchase of company shares. On July 8, 2025, she sold 3,598 shares at $54.48 per share. On July 10, 2025, she sold 4,254 shares at $56.74 per share and bought 20,000 shares at $8.11 per share. On July 9, 2025, she sold 2,092 shares at $57.08 per share and 19,792 shares at $56.43 per share, while also purchasing 20,000 shares at $8.11 per share. On July 10, 2025, she sold 15,746 shares at $57.62 per share and on July 8, 2025, she sold 16,602 shares at $55.74 per share.